Thank you

This live web event has ended. Thank you for attending.

Description

Please Register Below for this FREE Accredited-CE Activity

Live Webinar - Tuesday, July 27th – 7:00 pm – 8:30 pm ET

ACTIVITY OVERVIEW
Although there is no medication that can fully prevent or reverse the neurologic deterioration associated with multiple sclerosis (MS), the use of disease-modifying therapy (DMT) is widely recommended to favorably impact prognosis and reduce disability. The number of DMTs now approved by the US Food and Drug Administration has grown substantially, resulting in more options for patients, but also increasing the complexity of starting, stopping, and switching treatments for healthcare providers (HCPs), who must consider the different modes of administration (injectable, oral, or intravenous), pharmacologic profiles, and benefit-risk profiles, in the context of individual- and disease-specific factors. Thus, although it is encouraging to have many options that have been shown to reduce the frequency and severity of relapses, to limit the development of new lesion activity, and to delay the progression of disability, many clinicians struggle to find the time and skills needed to appraise the large body of available safety and efficacy data for these DMTs and to translate that information into optimal treatment choices for their patients. Furthermore, suboptimal management of the whole patient (ie, focusing on the symptoms or relapses while ignoring other impacts and burdens on the patient), and the lack of shared decision-making may result in the selection of a treatment approach that is out of sync with an individual’s values, preferences, and therapy goals.

Management of MS as a chronic, multifaceted disease requires multidisciplinary care from a collaborative team of specialty and primary care HCPs. This opportunity seeks to facilitate this team-based care by providing education in a format that addresses both the unique and common educational needs of specialty and primary care HCPs, provides a forum in which to share the latest evidence-based information, and explores best practices for MS care in a primary care setting, specialty setting, and collaborative setting.

TARGET AUDIENCE
This activity is intended for Primary care clinicians (physicians, NPs, PAs), nurses, neurology clinicians (physicians, NPs, PAs), advanced practice nurses and other healthcare providers who may participate in the assessment and care of individuals with MS.

LEARNING OBJECTIVES
Upon completion of this activity, the learner should be able to:
• Facilitate strategies that support the early recognition and treatment of multiple sclerosis
• Assess clinical trial and real-world efficacy and safety data for DMTs recently approved for relapsing and progressive forms of MS 
• Propose effective shared decision making and collaborative care strategies to optimize MS management plans 


FACULTY
Scott Newsome, DO, MSCS, FAAN, FANA (Chairperson)
Associate Professor of Neurology
Director, Neurosciences Consultation and Infusion Center at Green Spring Station
Director, Stiff Person Syndrome Center
Co-Director, Multiple Sclerosis Experimental Therapeutics Program
Co-Director, Johns Hopkins Neuroimmunology Clinical Fellowship Program
Member, Miller-Coulson Academy of Clinical Excellence
Johns Hopkins Hospital
Division of Neuroimmunology and Neuroinfectious Diseases
Baltimore, Maryland

Lisa Fox, PA
Department Associate Director
Neurology Outpatient Infusion Center
Johns Hopkins Medical Center
Baltimore, Maryland

Jiwon Oh, MD, PhD, FRCPC
Staff Neurologist
Medical Director, of the Barl Multiple Sclerosis Program
St. Michael’s Hospital
University of Toronto
Toronto, Canada


COMMERCIAL SUPPORT
This activity is supported by an educational grant from Biogen and Bristol-Myers Squibb.


This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Johns Hopkins University School of Medicine and Catalyst Medical Education, LLC. The Johns Hopkins University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

This nursing continuing professional development activity is jointly provided with The Institute for Johns Hopkins Nursing. The Institute for Johns Hopkins Nursing is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

Credit Designation Statements
Physicians
The Johns Hopkins University School of Medicine designates this live activity. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing
To receive contact hours, you must be present for the entire program. You must sign in to verify your attendance each day and complete the evaluation form. At the end of the program, you will be provided with a certificate stating the contact hours for this program when you hand in your evaluation.

How to Participate in This Activity and Obtain CME Credit
Statements of credit will be awarded based on the participant reviewing activity, scoring a 70% or higher on the post test, and completing and submitting an activity evaluation. A statement of credit will be available upon completion of an online evaluation/claimed credit form. You must participate in the entire activity to receive credit. There is no fee to participate in this activity.

How to Participate in This Activity and Obtain CME Credit
To receive contact hours and a completion certificate, you must review the entire program, score a 70% or higher on the post test, and complete and submit an activity evaluation.

Policy on Presenter and Provider Disclosures
It is the policy of the Johns Hopkins School of Medicine that the presenter and provider globally disclose conflicts of interest. The Johns Hopkins School of Medicine OCME has established policies that will identify and resolve conflicts of interest prior to this educational activity.

It is the policy of The Institute for Johns Hopkins Nursing to require our continuing nursing education program faculty and planning committee members to disclose any financial relationships with companies providing program funding or manufacturers of any commercial products discussed in the program. The Institute for Johns Hopkins Nursing has established policies to identify and mitigate relevant financial relationships.

Faculty
Scott Newsome, DO, MSCS, FAAN, FANA, has disclosed the following relevant financial relationships:
Advisor: Autobahn Therapeutics, BioIncept.
Advisory Board: Biogen Idec, Bristol Myers Squibb, EMD Serono, Genentech, Inc., Greenwich Biosciences, Novartis AG.
Clinical Adjudication Committee Member: MedDay Pharmaceuticals.
Consultant: Biogen Idec, BioIncept, Bristol Myers Squibb, EMD Serono, Genentech, Inc., Greenwich Biosciences, Novartis AG.
Principal Investigator: Biogen Idec, Genentech, Inc., Roche.

Lisa Fox, PA, has disclosed the following relevant financial relationships:
Consultant: Biogen Idec, Genentech, Inc., Genzyme Corporation, Novartis AG.

Jiwon Oh, MD, PhD, FRCPC, has disclosed the following relevant financial relationships:
Consultant: Biogen Idec, EMD Serono, Genzyme Corporation, Novartis AG, Roche.

Staff/Reviewers
Catalyst Medical Education, LLC Planners and Reviewers, have disclosed no financial relationships.
All the relevant financial relationships listed for these individuals have been mitigated.

Disclaimer Statement
The opinions and recommendations expressed by faculty and other experts whose input is included in this program are their own. This live activity is produced for educational purposed only. Use of Johns Hopkins School of Medicine name implies review of educational format design and approach. Please review the complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings, and adverse effects before administering pharmacologic therapy to patients.

Johns Hopkins Statements of Responsibility
The Johns Hopkins School of Medicine takes responsibility for the content, quality, and scientific integrity of this CME activity.

The Institute for Johns Hopkins Nursing takes responsibility for the content, quality, and scientific integrity of this CNE activity.

Copyright Statement
All rights reserved—The Johns Hopkins University School of Medicine and the Institute for Johns Hopkins Nursing. No part of this activity may be used or reproduced in any manner whatsoever without written permission except in the case of brief quotations embodied in articles or reviews.